Search Results 11-20 of 31281 for Relapse
A Study to Assess Impulsivity and its Association with Post-Treatment Relapse in Subjects with Substance Use Disorders · Overview · Participation eligibility.
This treatment is a monoclonal antibody that decreases annual relapse rates and demonstrates MRI benefits. This drug helps reduce relapses of MS by targeting a ...
Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI. By. Joe Dangor. October 5, 2016. Share this: Share to facebook · Share to ...
... relapses or slips. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Common relapse dangers to be aware of: Being in the presence of drugs or alcohol. Having alcohol in the house for friends and events. Being too busy to go to ...
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Relapse in Aggressive B-cell Non-Hodgkin Lymphomas · Overview · Participation eligibility.
Cancer recurrences are diagnosed just like any other cancer. Your health care provider might suspect a cancer recurrence based on certain tests, or you might ...
It decreases the relapse rate of MS . Possible side effects are elevated blood pressure, infections and liver inflammation. The maintenance dose is once a day.
Alcohol use disorder relapse factors: A systematic review. Psychiatry Research. 2019; doi:10.1016/j.psychres.2019.05.038. Thiamin deficiency. Merck Manual ...
AML: Treatment of Relapse after Transplant or Extended Maintenance of Remission – Investigational Study (ARTEMIS) Effectiveness of MT-401 in Patients with AML ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.